During Week 34, seasonal influenza activity remained low nationally.
In clinical labs, 0.4% of specimens tested positive for influenza.
In public health labs, influenza A(H1N1)pdm09, A(H3N2), and B viruses were all co-circulating.
Genetic and antigenic characterization of influenza viruses is ongoing.
Outpatient visits for respiratory illness were 1.8%, below the national baseline.
No jurisdictions experienced moderate, high, or very high ILI activity.
FluSurv-NET reported a weekly hospitalization rate of 0.0 per 100,000 population.
Mortality attributed to influenza remained stable, with 0.06% of deaths attributed to influenza.
One influenza-associated pediatric death was reported during Week 34, with a total of 195 deaths reported for the season.
CDC estimates at least 35 million flu illnesses, 400,000 hospitalizations, and 25,000 deaths have occurred this season.
Flu vaccines and antiviral drugs are recommended for prevention and treatment.
The influenza surveillance system provides essential data to monitor and predict flu activity.